Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
04 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...
Akers Biosciences Launches METRON(R) - the First and Only Disposable Breath Ketone Test
14 sept. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of...
Akers Biosciences Signs Agreement to Sell METRON(R) Breath Ketone Test Online, With Key Focus on Amazon Marketplace
06 mai 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., May 6, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...